Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.

Biotechnology

Alchemab Therapeutics

Jane Osbourn

Olivia Cavlan

Donna Finch

Paul Varley

Jenny Howell

Peter Catalano

Alexander Hewitson

Galina Nosovitskaya

Maureen West

Olivia Snudden

Ruth Jones

Sophie Sanford

Becky Eretta

Ralph Minter

Jake Galson

Research and Development

Leadership Team

Project Management

Finance and Administration

Teams at Alchemab Therapeutics

Research and Development

Leadership Team

Project Management

Finance and Administration